Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
3,03 USD | -1,30 % | -4,72 % | -7,20 % |
Resumen de negocios
Número de empleados: 31
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Therapeutics
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -60,62 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Australia, Switzerland and Spain
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -60,62 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Matthias Alder
CEO | Chief Executive Officer | 59 | 19/10/21 |
Chief Tech/Sci/R&D Officer | - | 01/03/19 | |
Eric Richman
BRD | Director/Board Member | 63 | 01/07/20 |
Comptroller/Controller/Auditor | 35 | 01/07/22 | |
Corporate Officer/Principal | - | - | |
Manolo Bellotto
PRN | Corporate Officer/Principal | 53 | 01/01/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Dov Goldstein
BRD | Director/Board Member | 56 | 01/01/21 |
Eric Richman
BRD | Director/Board Member | 63 | 01/07/20 |
Matthias Alder
CEO | Chief Executive Officer | 59 | 19/10/21 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 01/01/21 |
Director/Board Member | 68 | 01/01/21 | |
Jeffrey Riley
BRD | Director/Board Member | 61 | 01/05/19 |
Khalid Islam
FOU | Founder | 67 | 01/01/17 |
Claude Nicaise
BRD | Director/Board Member | 71 | 01/01/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 16 219 709 | 13 551 475 ( 83,55 %) | 0 | 83,55 % |
Información de la empresa
Gain Therapeutics, Inc.
4800 Montgomery Lane Suite 220
20814, Bethesda
+
http://www.gaintherapeutics.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-7,20 % | 49,15 M | |
+1,51 % | 42,75 mil M | |
+49,22 % | 41,61 mil M | |
+8,57 % | 41,34 mil M | |
-12,36 % | 26,59 mil M | |
+8,92 % | 25,49 mil M | |
-25,13 % | 18,12 mil M | |
+29,17 % | 12,24 mil M | |
-3,12 % | 11,76 mil M | |
+6,35 % | 11 mil M |
- Bolsa de valores
- Acciones
- Acción GANX
- Empresa Gain Therapeutics, Inc.